High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients

Cellular Oncology

Volumn 35, Issue 6, 2012, Pages 461-471

  Tsai, Jong Rung ^a,b   Wang, Hui Min ^c   Liu, Po Len ^a   Chen, Yung Hsiang ^d   Yang, Ming Chan ^e   Chou, Shah Hwa ^a,b   Cheng, Yu Jen ^f   Yin, Wei Hsian ^g   Hwang, Jhi Jhu ^a,b   Chong, Inn Wen ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e YUAN'S GENERAL HOSPITAL   (Taiwan)

^f I SHOU UNIVERSITY   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Heme Oxygenase 1; Metastasis; Non small cell lung cancer; Prognosis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; API 59; CD147 ANTIGEN; GELATINASE B; HEME OXYGENASE 1; PROTEIN KINASE B INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; BIOSYNTHESIS; CANCER STAGING; ENZYMOLOGY; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG TUMOR; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; HEME OXYGENASE-1; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84879216859     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0105-5     Document Type: Article

References (52)

1. M.D. Maines, Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 2, 2557-2568 (1988)
2. J.C. Becker, H. Fukui, Y. Imai, A. Sekikawa, T. Kimura, H. Yamagishi et al., Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer. Scand. J. Gastroenterol. 42, 852-858 (2007)
3. M.D. Maines, The heme oxygenase system: A regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554 (1997)
4. W. Durante, Heme oxygenase-1 in growth control and its clinical application to vascular disease. J. Cell. Physiol. 195, 373-382 (2003)
5. D. Morse, A.M. Choi, Heme oxygenase-1: The "emerging molecule" has arrived. American journal of respiratory cell and molecular biology 27, 8-16 (2002)
6. S.S. Lee, S.F. Yang, C.H. Tsai, M.C. Chou, M.Y. Chou, Y.C. Chang, Upregulation of heme oxygenase-1 expression in arecaquid-chewing-associated oral squamous cell carcinoma. Journal of the Formosan Medical Association Taiwan yi zhi. 107, 355-363 (2008)
7. S. Ishikawa, S. Tamaki, M. Ohata, K. Arihara, M. Itoh, Heme induces DNA damage and hyperproliferation of colonic epithelial cells via hydrogen peroxide produced by heme oxygenase: A possible mechanism of heme-induced colon cancer. Mol. Nutr. Food. Res. 54, 1182-1191 (2010)
8. T. Ishikawa, N. Yoshida, H. Higashihara, M. Inoue, K. Uchiyama, T. Takagi et al., Different effects of constitutive nitric oxide synthase and heme oxygenase on pulmonary or liver metastasis of colon cancer in mice. Clinical & experimental metastasis. 20, 445-450 (2003)
9. G. Gueron, A. De Siervi, M. Ferrando, M. Salierno, P. De Luca, B. Elguero et al., Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol. Cancer Res. 7, 1745-1755 (2009)
10. M.A. Alaoui-Jamali, T.A. Bismar, A. Gupta, W.A. Szarek, J. Su, W. Song et al., A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res. 69, 8017-8024 (2009)
11. H.R. Kim, S. Kim, E.J. Kim, J.H. Park, S.H. Yang, E.T. Jeong et al., Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin. Lung Cancer 60, 47-56 (2008)
12. K. Hirai, T. Sasahira, H. Ohmori, K. Fujii, H. Kuniyasu, Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int. J. Cancer 120, 500-505 (2007)
13. P. Boschetto, E. Zeni, L. Mazzetti, D. Miotto, N. Lo Cascio, P. Maestrelli et al., Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer. Lung Cancer 59, 192-197 (2008)
14. M.S. Degese, J.E. Mendizabal, N.A. Gandini, J.S. Gutkind, A. Molinolo, S.M. Hewitt et al., Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer 77, 168-175 (2012)
15. A. Jozkowicz, H. Was, J. Dulak, Heme oxygenase-1 in tumors: Is it a false friend? Antioxid. Redox. Signal. 9, 2099-2117 (2007)
16. R.S. Herbst, Review of epidermal growth factor receptor biology. Int. J. Radiat. Oncol. Biol. Phys. 59, 21-26 (2004)
17. H. Sasaki, H. Yukiue, K. Mizuno, A. Sekimura, A. Konishi, M. Yano et al., Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer. International journal of clinical oncology/Japan Society of Clinical Oncology. 8, 79-82 (2003)
18. T. Kanekura, X. Chen, CD147/basigin promotes progression of malignant melanoma and other cancers. J. Dermatol. Sci. 57, 149-154 (2010)
19. J. Xu, H.Y. Xu, Q. Zhang, F. Song, J.L. Jiang, X.M. Yang et al., HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol. Cancer Res. 5, 605-614 (2007)
20. H. Voigt, C.S. Vetter-Kauczok, D. Schrama, U.B. Hofmann, J.C. Becker, R. Houben, CD147 impacts angiogenesis and metastasis formation. Cancer investigation. 27, 329-333 (2009)
21. H. Was, J. Dulak, A. Jozkowicz, Heme oxygenase-1 in tumor biology and therapy. Current drug targets. 11, 1551-1570 (2010)
22. H. Was, T. Cichon, R. Smolarczyk, D. Rudnicka, M. Stopa, C. Chevalier et al., Overexpression of heme oxygenase-1 in murine melanoma: Increased proliferation and viability of tumor cells, decreased survival of mice. Am. J. Pathol. 169, 2181-2198 (2006)
23. M.H. Tsuji, T. Yanagawa, S. Iwasa, K. Tabuchi, K. Onizawa, S. Bannai et al., Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Lett. 138, 53-59 (1999)
24. M. Sunamura, D.G. Duda, M.H. Ghattas, L. Lozonschi, F. Motoi, J. Yamauchi et al., Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6, 15-24 (2003)
25. P. Boschetto, E. Zeni, L. Mazzetti, D. Miotto, N.L. Cascio, P. Maestrelli et al., Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer. Lung Cancer 59, 192-197 (2008)
26. C.K. Andreadi, L.M. Howells, P.A. Atherfold, M.M. Manson, Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol. Pharmacol. 69, 1033-1040 (2006)
27. S. Kocanova, E. Buytaert, J.Y. Matroule, J. Piette, J. Golab, P. de Witte et al., Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis 12, 731-741 (2007)
28. E.J. Joung, M.H. Li, H.G. Lee, N. Somparn, Y.S. Jung, H.K. Na et al., Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:quinone oxidoreductase as a potential target. Antioxid. Redox. Signal. 9, 2087-2098 (2007)
29. C.F. Mountain, Revisions in the International System for Staging Lung Cancer. Chest 111, 1710-1717 (1997)
30. V.K. Sarhadi, H. Wikman, K. Salmenkivi, E. Kuosma, T. Sioris, J. Salo et al., Increased expression of high mobility group A proteins in lung cancer. J. Pathol. 209, 206-212 (2006)
31. H. Wikman, E. Kettunen, J.K. Seppanen, A. Karjalainen, J. Hollmen, S. Anttila et al., Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21, 5804-5813 (2002)
32. T.C. Wu, Y.H. Chen, H.B. Leu, Y.L. Chen, F.Y. Lin, S.J. Lin et al., Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and 9 in experimental atherosclerosis. Free Radic. Biol. Med. 43, 1508-1522 (2007)
33. S.J. Lin, I.T. Lee, Y.H. Chen, F.Y. Lin, L.M. Sheu, H.H. Ku et al., Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPStreated human aortic smooth muscle cells. J. Cell. Biochem. 100, 372-384 (2007)
34. H.M. Wang, C.C. Chiu, P.F. Wu, C.Y. Chen, Subamolide E from Cinnamomum subavenium induces sub-G1 cell-cycle arrest and caspase-dependent apoptosis and reduces the migration ability of human melanoma cells. J. Agric. Food Chem. 59, 8187-8192 (2011)
35. F. Shiraishi, L.M. Curtis, L. Truong, K. Poss, G.A. Visner, K. Madsen, H.S. Nick, A. Agarwal, Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278, F726-F736 (2000)
36. A. Albini, R. Benelli, The chemoinvasion assay: A method to assess tumor and endothelial cell invasion and its modulation. Nat. Protoc. 2(504-11) (2007)
37. S. Tang, K.G. Morgan, C. Parker, J.A. Ware, Requirement for protein kinase C theta for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells. J. Biol. Chem. 272, 28704-28711 (1997)
38. G. Wang, E. Reed, Q.Q. Li, Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). Oncol. Rep. 12, 955-965 (2004)
39. N. Grabinski, K. Bartkowiak, K. Grupp, B. Brandt, K. Pantel, M. Jucker, Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells. Cell. Signal. 23, 1952-1960 (2011)
40. L. Mansi, E. Viel, E. Curtit, J. Medioni, C. Le Tourneau, Targeting the RAS signalling pathway in cancer therapy. Nat. Rev. Cancer 3, 11-22 (2003)
41. R. Tenhunen, H.S. Marver, R. Schmid, The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U. S. A. 61, 748-755 (1968)
42. K. Doi, T. Akaike, S. Fujii, S. Tanaka, N. Ikebe, T. Beppu et al., Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br. J. Cancer 80, 1945-1954 (1999)
43. E. Hara, K. Takahashi, T. Tominaga, T. Kumabe, T. Kayama, H. Suzuki et al., Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochem. Biophys. Res. Commun. 224, 153-158 (1996)
44. M.Y. Li, J. Yip, M.K. Hsin, T.S. Mok, Y. Wu, M.J. Underwood et al., Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis. Eur. Respir. J. 32, 911-923 (2008)
45. H. Kuroda, M. Takeno, S. Murakami, N. Miyazawa, T. Kaneko, Y. Ishigatsubo, Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells. Lung Cancer 67, 31-36 (2010)
46. P.L. Liu, J.R. Tsai, A.L. Charles, J.J. Hwang, S.H. Chou, Y.H. Ping et al., Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factorkappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol. Nutr. Food Res. 54(2), S196-S204 (2010)
47. T. Yanagawa, K. Omura, H. Harada, K. Nakaso, S. Iwasa, Y. Koyama et al., Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas. Oral oncology. 40, 21-27 (2004)
48. G. De Palma, P. Mozzoni, O. Acampa, E. Internullo, P. Carbognani, M. Rusca et al., Expression levels of some antioxidant and epidermal growth factor receptor genes in patients with early-stage non-small cell lung cancer. Journal of nucleic acids (2010).
49. M. Mareel, I. Madani, Tumour-associated host cells participating at invasion and metastasis: Targets for therapy? Acta. chirurgica. Belgica. 106, 635-640 (2006)
50. A. Prawan, J.K. Kundu, Y.J. Surh, Molecular basis of heme oxygenase-1 induction: Implications for chemoprevention and chemoprotection. Antioxid. Redox. Signal. 7, 1688-1703 (2005)
51. J. Alam, C. Wicks, D. Stewart, P. Gong, C. Touchard, S. Otterbein et al., Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J. Biol. Chem. 275, 27694-27702 (2000)
52. E.H. Kim, D.H. Kim, H.K. Na, Y.J. Surh, Effects of cyclopentenone prostaglandins on the expression of heme oxygenase-1 in MCF-7 cells. Ann. N. Y. Acad. Sci. 1030, 493-500 (2004)